Bellerophon Therapeutics Stock Forecast
Bellerophon Therapeutics stock price up 1.66% on Thursday
(Updated on Apr 25, 2024)
The Bellerophon Therapeutics stock price gained 1.66% on the last trading day (Thursday, 25th Apr 2024), rising from $0.0541 to $0.0550. During the last trading day the stock fluctuated 0.92% from a day low at $0.0545 to a day high of $0.0550. The price has risen in 5 of the last 10 days and is up by 3.58% over the past 2 weeks. Volume fell on the last day by -37 thousand shares and in total, 10 thousand shares were bought and sold for approximately $557.48 . You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.89% during the next 3 months and, with a 90% probability hold a price between $0.0473 and $0.0580 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
BLPH Signals & Forecast
There are few to no technical positive signals at the moment. The Bellerophon Therapeutics stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.0551. On a fall, the stock will find some support from the short-term average at $0.0550. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, April 10, 2024, and so far it has fallen -8.33%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.
A sell signal from a double top formation was found on Wednesday, April 10, 2024 with a target of $0.0578. Despite whether the objective of the signal formation has been reached the stock may continue to fall.
Support, Risk & Stop-loss for Bellerophon Therapeutics stock
Bellerophon Therapeutics finds support from accumulated volume at $0.0535 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0005 between high and low, or 0.92%. For the last week the stock has had daily average volatility of 7.40%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (BLPH) For The Upcoming Trading Day Of Friday 26th
For the upcoming trading day on Friday, 26th we expect Bellerophon Therapeutics to open at $0.0548, and during the day (based on 14 day Average True Range), to move between $0.0500 and $0.0600, which gives a possible trading interval of +/-$0.0050 (+/-9.11%) up or down from last closing price. If Bellerophon Therapeutics takes out the full calculated possible swing range there will be an estimated 18.21% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.0535 (2.73%) than the resistance at $0.0570 (3.64%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Bellerophon Therapeutics stock A Buy?
Bellerophon Therapeutics holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score: -1.698 Sell Candidate Unchanged
Predicted Opening Price for Bellerophon Therapeutics of Friday, April 26, 2024
| Fair opening price April 26, 2024 | Current price |
|---|---|
| $0.0548 ( 0.303%) | $0.0550 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for BLPH
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.0553 | 0.606 % | |
| R2 | 0.0551 | 0.259 % | ||
| R1 | 0.0550 | 0.0442 % | ||
| Current price: | 0.0550 | |||
| Support | S1 | 0.0546 | -0.650 % | |
| S2 | 0.0545 | -0.86 % | ||
| S3 | 0.0543 | -1.21 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.0640 | 16.36 % | |
| R2 | 0.0571 | 3.73 % | ||
| R1 | 0.0570 | 3.64 % | ||
| Current price | 0.0550 | |||
| Support | S1 | 0.0535 | -2.73% | |
| S2 | 0.0533 | -3.18% | ||
| S3 | 0.0510 | -7.27% |
FAQ
Click here for our free guide on how to buy Bellerophon Therapeutics Stock.
